Last updated: December 2, 2023
Sponsor: University of British Columbia
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cystic Fibrosis
Lung Disease
Treatment
N/AClinical Study ID
NCT04735952
331178/ H20-00071
R56HL139846
Pro00043176
HILL18A0
Ages > 3 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aim 1, Cross-Sectional IInclusion Criteria:
- Male or female, ages 8 years and older
- Diagnosis of CF based on sweat chloride ≥ 60 mmol/L and/or 2 known CF mutations
- @ BC Children's Hospital only- Non-expectorators are eligible if having a clinicallyindicated OP swab.
- FEV1 ≥ 30% predicted for spontaneous expectorators or FEV1 ≥ 40% predicted forsubjects undergoing sputum induction
- Either P. aeruginosa (Pa) negative or chronically infected with P. aeruginosa (Papositive) as defined below: a. P. aeruginosa negative: must meet one of the following criteria: i: No growth of Pain previous 12 months and ≥ 4 consecutive Pa-negative cultures, OR ii: No history ofPa positive airway cultures (sputum, OP, Bronchoalveolar lavage) b. P. aeruginosapositive i: Over 50% of cultures positive and at least 2 cultures positive for Pa inprevious 18 months
- Willing to participate in and comply with the study procedures and willingness of thesubject, parent or legally authorized representative to provide written informedconsent.
Exclusion
Exclusion criteria:
- Age < 8 years
- Intermittently infected with Pa
- FEV1 < 30%
- History of lung transplant
- Presence of a condition or abnormality that in the opinion of the PrincipalInvestigator would compromise the safety of the subject or the quality of the data. Aim 2, Longitudinal Inclusion Criteria, Expectorating Cohort (n=48):
- Male or female, ages 8-16 years
- Diagnosis of CF based on sweat chloride ≥ 60 mmol/L and/or 2 known CF mutations
- @ BC Children's Hospital only- Non-expectorators are eligible if having a clinicallyindicated OP swab.
- FEV1 ≥ 30% predicted for spontaneous expectorators or FEV1 ≥ 40% predicted forsubjects undergoing sputum induction
- P. aeruginosa negative, based on one of the following criteria:
- No growth of Pa in previous 12 months and ≥ 4 consecutive Pa-negative cultures
- No history of Pa positive airway cultures (sputum, OP, bronchoalveolar lavage)
- Willing to participate in and comply with the study procedures and willingness of thesubject, parent or legally authorized representative to provide written informedconsent. Exclusion criteria:
- Age < 8 years
- Intermittently or chronically infected with Pa
- Unable to expectorate sputum or undergo sputum induction
- FEV1 < 30%
- History of lung transplant
- Presence of a condition or abnormality that in the opinion of the PrincipalInvestigator would compromise the safety of the subject or the quality of the data. Inclusion Criteria, Non-Expectorating Cohort (n=10):
- Male or female, ages 3-8 years
- Diagnosis of CF based on sweat chloride ≥ 60 mmol/L and/or 2 known CF mutations 3.FEV1 ≥ 30%
- Unable to expectorate sputum 5. P. aeruginosa negative, based on one of the followingcriteria:
- No growth of Pa in previous 12 months and ≥ 4 consecutive Pa-negative cultures
- No history of Pa positive airway cultures (sputum, OP, bronchoalveolar lavage) 6.Willing to participate in and comply with the study procedures and willingness of thesubject, parent or legally authorized representative to provide written informedconsent. Exclusion criteria:
- Age < 3 years
- Intermittently or chronically infected with Pa
- FEV1 < 30%
- History of lung transplant
- Presence of a condition or abnormality that in the opinion of the PrincipalInvestigator would compromise the safety of the subject or the quality of the data.
Study Design
Total Participants: 300
Study Start date:
May 03, 2019
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
BC Children's Hospital
Vancouver, British Columbia V6H3N1
CanadaActive - Recruiting
St. Paul's Hospital
Vancouver, British Columbia V6Z1Y6
CanadaActive - Recruiting
Phoenix Children's Hospital
Phoenix, Arizona 85016
United StatesCompleted
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesCompleted
National Jewish Health
Denver, Colorado 80206
United StatesCompleted
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire 03756
United StatesSite Not Available
Cincinnati Children's Hospital
Cincinnati, Ohio 45229-3039
United StatesCompleted
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.